VPA |
Affects expression of BDFN mRNA in brain tissue |
|
+ |
+ |
+ |
+ |
+ |
|
R |
+ |
+ |
+ |
– |
+ |
|
Almeida et al., 2014; Banerjee et al., 2014; Kim et al., 2014a; Reynolds et al., 2021
|
|
|
|
|
|
|
|
F |
+ |
+ |
+ |
– |
+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PPA |
Reactive astrocyte keratinization of brain tissue; microglia are activated; oxidative stress markers rise; glutathione declines |
|
NT |
NT |
NT |
NT |
NT |
|
R |
+ |
+ |
+ |
– |
+ |
|
El-Ansary et al., 2012; Foley et al., 2015; MacFabe et al., 2011; Shultz et al., 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BPA |
Changes in number of neurons and glia in the medial prefrontal lobe |
|
+ |
+ |
+ |
+ |
+ |
|
R |
+ |
+ |
+ |
– |
+ |
|
Braniste et al., 2010; Sadowski et al., 2014; Vermeer et al., 2014; Xu et al., 2015
|
Sevoflurane |
Increases the number of apoptotic cells in brain; inhibits the axon development of hippocampal neurons |
|
NT |
NT |
NT |
NT |
NT |
|
R |
+ |
+ |
+ |
– |
+ |
|
Chen et al., 2020; Jin et al., 2020
|
MIA |
Abnormal increase of offspring’s brain volume |
|
+ |
+ |
+ |
+ |
+ |
|
M |
+ |
+ |
+ |
– |
+ |
|
Bauman et al., 2013; Braunschweig et al., 2012; Breach et al., 2021
|
|
|
|
|
|
|
|
R |
+ |
+ |
+ |
– |
+ |
|
BDV |
Abnormal hippocampal and cerebellar development |
|
+ |
+ |
+ |
+ |
+ |
|
R |
+ |
+ |
+ |
– |
+ |
|
Pletnikov et al., 2002; Taieb et al., 2001
|
GM |
Regulation of neuroactive metabolites |
|
+ |
+ |
+ |
+ |
+ |
|
M |
+ |
+ |
+ |
– |
+ |
|
Sharon et al., 2019
|
|
|
|
|
|
|
|
R |
+ |
+ |
+ |
– |
+ |
|
|
|
|
|
|
|
|
F |
+ |
+ |
+ |
– |
+ |
|
|
|
|
|
|
|
|
I |
+ |
+ |
+ |
– |
+ |
|
RCS |
Changes in neurotransmitter and corticosterone levels |
|
NT |
NT |
NT |
NT |
NT |
|
R |
+ |
+ |
+ |
– |
+ |
|
Hata et al., 1987; Namimatsu et al., 1992
|